Valence8 Us Lp Top Holdings and 13F Report (2024) About Valence8 Us LpInvestment ActivityValence8 Us Lp has $241.10 million in total holdings as of September 30, 2024.Valence8 Us Lp owns shares of 56 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 16.31% of the portfolio was purchased this quarter.About 0.59% of the portfolio was sold this quarter.This quarter, Valence8 Us Lp has purchased 9 new stocks and bought additional shares in 3 stocks.Valence8 Us Lp sold shares of 4 stocks and completely divested from 0 stocks this quarter.Largest Holdings iShares MSCI USA Quality Factor ETF $60,508,730Invesco QQQ $43,022,882iShares MSCI Intl Quality Factor ETF $42,580,772iShares MSCI EAFE Value ETF $22,965,171Vanguard Value ETF $16,868,699 Largest New Holdings this Quarter AstraZeneca $4,986,240 HoldingAmgen $1,288,840 HoldingSoleno Therapeutics $1,121,181 HoldingInsmed $1,055,945 HoldingJazz Pharmaceuticals $999,236 Holding Largest Purchases this Quarter iShares MSCI USA Quality Factor ETF 36,424 shares (about $6.53M)Invesco QQQ 11,438 shares (about $5.58M)iShares MSCI Intl Quality Factor ETF 134,097 shares (about $5.56M)AstraZeneca 64,000 shares (about $4.99M)Amgen 4,000 shares (about $1.29M) Largest Sales this Quarter Vanguard Value ETF 3,373 shares (about $588.82K)Utilities Select Sector SPDR Fund 3,648 shares (about $294.69K)iShares MSCI United Kingdom ETF 7,590 shares (about $283.94K)Consumer Staples Select Sector SPDR Fund 3,033 shares (about $251.74K) Sector Allocation Over TimeMap of 500 Largest Holdings ofValence8 Us Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorQUALiShares MSCI USA Quality Factor ETF$60,508,730$6,530,823 ▲12.1%337,47225.1%ETFQQQInvesco QQQ$43,022,882$5,582,545 ▲14.9%88,14917.8%FinanceIQLTiShares MSCI Intl Quality Factor ETF$42,580,772$5,563,685 ▲15.0%1,026,29017.7%ETFEFViShares MSCI EAFE Value ETF$22,965,1710.0%399,1869.5%ETFVTVVanguard Value ETF$16,868,699$588,825 ▼-3.4%96,6307.0%ETFXLPConsumer Staples Select Sector SPDR Fund$13,717,161$251,739 ▼-1.8%165,2675.7%ETFEWUiShares MSCI United Kingdom ETF$7,831,559$283,942 ▼-3.5%209,3443.2%ETFEWJiShares MSCI Japan ETF$7,771,6760.0%108,6343.2%ETFAZNAstraZeneca$4,986,240$4,986,240 ▲New Holding64,0002.1%MedicalXLUUtilities Select Sector SPDR Fund$4,195,713$294,685 ▼-6.6%51,9401.7%ETFAMGNAmgen$1,288,840$1,288,840 ▲New Holding4,0000.5%MedicalSLNOSoleno Therapeutics$1,121,181$1,121,181 ▲New Holding22,2060.5%MedicalINSMInsmed$1,055,945$1,055,945 ▲New Holding14,4650.4%MedicalJAZZJazz Pharmaceuticals$999,236$999,236 ▲New Holding8,9690.4%MedicalBMYBristol-Myers Squibb$920,196$920,196 ▲New Holding17,7850.4%MedicalASNDAscendis Pharma A/S$684,586$684,586 ▲New Holding4,5850.3%MedicalRAREUltragenyx Pharmaceutical$618,883$618,883 ▲New Holding11,1410.3%MedicalCRSPCRISPR Therapeutics$615,438$615,438 ▲New Holding13,1000.3%MedicalINDVIndivior$564,186$564,186 ▲New Holding57,2930.2%MedicalLLYEli Lilly and Company$560,800$560,800 ▲New Holding6330.2%MedicalARGXargenx$516,602$516,602 ▲New Holding9530.2%MedicalKROSKeros Therapeutics$466,012$466,012 ▲New Holding8,0250.2%MedicalNVONovo Nordisk A/S$464,373$464,373 ▲New Holding3,9000.2%MedicalJANXJanux Therapeutics$461,433$461,433 ▲New Holding10,1570.2%MedicalNUVLNuvalent$420,965$420,965 ▲New Holding4,1150.2%MedicalSAVACassava Sciences$414,963$414,963 ▲New Holding14,1000.2%MedicalAPLSApellis Pharmaceuticals$377,804$377,804 ▲New Holding13,1000.2%MedicalAVADEL PHARMACEUTICALS PLC$343,613$343,613 ▲New Holding26,2000.1%COM SHSCRNXCrinetics Pharmaceuticals$341,552$341,552 ▲New Holding6,6840.1%MedicalTYRATyra Biosciences$310,050$310,050 ▲New Holding13,1880.1%MedicalAPOGEE THERAPEUTICS INC$307,798$307,798 ▲New Holding5,2400.1%COMALTAltimmune$305,158$305,158 ▲New Holding49,7000.1%MedicalVRDNViridian Therapeutics$298,025$298,025 ▲New Holding13,1000.1%MedicalPCVXVaxcyte$282,018$282,018 ▲New Holding2,4680.1%MedicalMRNAModerna$274,003$274,003 ▲New Holding4,1000.1%MedicalNTLAIntellia Therapeutics$267,561$267,561 ▲New Holding13,0200.1%MedicalVIRVir Biotechnology$252,039$252,039 ▲New Holding33,6500.1%MedicalBPMCBlueprint Medicines$242,165$242,165 ▲New Holding2,6180.1%MedicalCLDXCelldex Therapeutics$220,935$220,935 ▲New Holding6,5000.1%MedicalENTAEnanta Pharmaceuticals$206,568$206,568 ▲New Holding19,9390.1%MedicalRLAYRelay Therapeutics$185,496$185,496 ▲New Holding26,2000.1%MedicalAPLTApplied Therapeutics$172,550$172,550 ▲New Holding20,3000.1%MedicalZVRAZevra Therapeutics$149,876$149,876 ▲New Holding21,5960.1%MedicalERASErasca$128,100$128,100 ▲New Holding46,9230.1%MedicalIOVAIovance Biotherapeutics$123,009$123,009 ▲New Holding13,1000.1%MedicalSLDBSolid Biosciences$109,624$109,624 ▲New Holding15,7280.0%MedicalVTGNVistagen Therapeutics$103,472$103,472 ▲New Holding34,3760.0%MedicalBCRXBioCryst Pharmaceuticals$99,560$99,560 ▲New Holding13,1000.0%MedicalZURAZura Bio$71,030$71,030 ▲New Holding17,4950.0%MedicalALECAlector$68,539$68,539 ▲New Holding14,7080.0%MedicalELYMEliem Therapeutics$61,309$61,309 ▲New Holding12,0450.0%MedicalCCCCC4 Therapeutics$59,850$59,850 ▲New Holding10,5000.0%MedicalLPTXLeap Therapeutics$47,573$47,573 ▲New Holding18,5110.0%MedicalNKTRNektar Therapeutics$33,939$33,939 ▲New Holding26,1070.0%MedicalGOSSGossamer Bio$20,418$20,418 ▲New Holding20,7000.0%MedicalKZRKezar Life Sciences$16,342$16,342 ▲New Holding21,1360.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
